Profile
| Metric | Value |
|---|---|
| Full Name | AtriCure, Inc. |
| Ticker | NASDAQ: ATRC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | atricure.com |
| Employees | 1,300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $39.06 | |
| Price, 1D Change | -5.79% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.95 | |
| Revenue | $465M | |
| Revenue, 1Y Change | +16.55% | |
| EPS | -$0.95 | |
| EPS, 1Y Change | -44.79% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.95 | |
| EPS Estimate | -$0.24 | |
| EPS Est. Change | +74.86% | |
| Revenue | $465.31M | |
| Revenue Estimate | $534.50M | |
| Revenue Est. Change | +14.87% | |
| Current Price | $39.06 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +28.01% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.76 | -$0.66 | +13.51% | |
| -$0.74 | -$0.95 | -28.00% | |
| -$0.24 | N/A | +74.86% | |
| -$0.13 | N/A | +86.24% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $396.41M | $399.25M | +0.72% | |
| $462.41M | $465.31M | +0.63% | |
| $534.50M | N/A | +14.87% | |
| $600.29M | N/A | +29.01% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +3.77% | |
| Price, 3Y | -9.44% | |
| Market Cap, 1Y | +5.57% | |
| Market Cap, 3Y | -3.30% | |
| Revenue, 1Y | +16.55% | |
| Revenue, 3Y | +69.62% | |
| EPS, 1Y | -44.79% | |
| EPS, 3Y | -187.28% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $39.06 | |
| SMA 200 | $34.86 | |
| SMA 200 vs Price | -10.76% | |
| SMA 50 | $37.85 | |
| SMA 50 vs Price | -3.10% | |
| Beta | 0.95 | |
| ATR | $1.93 | |
| 14-Day RSI | 48.69 | |
| 10-Day Volatility | 88.41% | |
| 1-Year Volatility | 47.68% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $465.31M | |
| EPS | -$0.95 | |
| Gross Profit | $347.52M | |
| Gross Margin | 74.69% | |
| Operating Profit | -$40.01M | |
| Operating Margin | -8.60% | |
| Net Income | -$44.70M | |
| Net Margin | -9.61% | |
| EBITDA | -$18.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.14 | |
| Current Ratio | 3.65 | |
| Quick Ratio | 2.62 | |
| - | ||
| F-Score | 5 | |
| Altman Z-Score | 7.88 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 3.75 | |
| PB Ratio | 4.08 | |
| EV/EBITDA | 173.97 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $460.97M | |
| Cash & Equivalents | $122.72M | |
| Total Assets | $609.33M | |
| Current Assets | $267.83M | |
| Total Liabilities | $148.36M | |
| Current Liabilities | $73.42M | |
| Total Debt | $76.53M | |
| Short Term Debt | $2.81M | |
| Accounts Payable | $25.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $505.32M | |
| Operating Expenses | $387.54M | |
| Cost Of Goods Sold | $117.78M | |
| SG&A | $0.00 | |
| D&A | $18.73M | |
| Interest Expense | $0.00 | |
| Income Tax | $1.02M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $11.14M | |
| CFI | $30.23M | |
| CFF | -$2.53M | |
| Capex | $11.46M | |
| Free Cash Flow | -$324.00K |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Canaccord Genuity | → | |
| Needham | → | |
| UBS | → | |
| Needham | → | |
| JMP Securities | → | |
| BTIG | → | |
| Citizens Capital Markets | → | |
| Canaccord Genuity | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with ATRC
FAQ
What is the ticker symbol for AtriCure, Inc.?
The ticker symbol for AtriCure, Inc. is NASDAQ:ATRC
Does AtriCure, Inc. pay dividends?
No, AtriCure, Inc. does not pay dividends
What sector is AtriCure, Inc. in?
AtriCure, Inc. is in the Healthcare sector
What industry is AtriCure, Inc. in?
AtriCure, Inc. is in the Medical Instruments & Supplies industry
What country is AtriCure, Inc. based in?
AtriCure, Inc. is headquartered in United States
When did AtriCure, Inc. go public?
AtriCure, Inc. initial public offering (IPO) was on August 5, 2005
Is AtriCure, Inc. in the S&P 500?
No, AtriCure, Inc. is not included in the S&P 500 index
Is AtriCure, Inc. in the NASDAQ 100?
No, AtriCure, Inc. is not included in the NASDAQ 100 index
Is AtriCure, Inc. in the Dow Jones?
No, AtriCure, Inc. is not included in the Dow Jones index
When was AtriCure, Inc. last earnings report?
AtriCure, Inc.'s most recent earnings report was on October 29, 2025
When does AtriCure, Inc. report earnings?
The next expected earnings date for AtriCure, Inc. is February 11, 2026
Data Sources & References
- ATRC Official Website www.atricure.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1323885/000132388525000103/0001323885-25-000103-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1323885/000132388525000009/0001323885-25-000009-index.htm
- ATRC Profile on Yahoo Finance finance.yahoo.com/quote/ATRC
- ATRC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atrc